Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key-Reference-Cited by-同舟云学术

Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key

Published:2018-08-27 Issue:1 Volume:78 Page:141-142
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

den Broeder Nathan^ORCID,Bouman Chantal A M,Kievit Wietske,van Herwaarden Noortje,van den Hoogen Frank H J,van Vollenhoven Ronald F,Bijlsma Hans W J,van der Maas Aatke,den Broeder Alfons A

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference4 articles.

1. van Herwaarden N , van der Maas A , Minten MJ , et al . Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial. BMJ 2015;350:h1389.doi:10.1136/bmj.h1389

2. Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study

3. Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial

4. Zinnige en duurzame zorg Advies uitgebracht door de Raad voor de Volksgezondheid en Zorg aan de minister. Welzijn en Sport, Zoetermeer: van Volksgezondheid, 2006.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease activity–guided dose optimization including discontinuation of TNF inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study;Rheumatology;2024-02-12

2. An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study;Diagnostics;2023-01-01

3. Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors;Pediatric Rheumatology;2022-12-05

4. Tapering biologics in axial spondyloarthritis: A systematic literature review;International Immunopharmacology;2022-11

5. Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial;Trials;2022-06-16